Hydrogen sulfide as a potential biomarker of asthma

Expert Review of Respiratory Medicine

Volumn 8, Issue 1, 2014, Pages 5-13

  Chung, Kian F ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

asthma; hydrogen sulfide; lung inflammation; nitric oxide

Indexed keywords

CARBON MONOXIDE; GASOTRANSMITTER; HYDROGEN SULFIDE; NITRIC OXIDE; NITROGEN OXIDE; PEROXYNITRITE; SUPEROXIDE;

AIRWAY CONSTRICTION; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ASTHMA; BREATHING; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; HYPOXIC LUNG VASOCONSTRICTION; INTRACELLULAR SIGNALING; LUNG FIBROSIS; LUNG FUNCTION; NEUROGENIC INFLAMMATION; NONHUMAN; PATHOGENESIS; PNEUMONIA; SPUTUM; SYNTHESIS; VASCULAR SMOOTH MUSCLE;

ASTHMA; BIOLOGICAL MARKERS; HUMANS; HYDROGEN SULFIDE; INFLAMMATION; LUNG; PHENOTYPE; SPUTUM;

EID: 84893026987     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2014.856267     Document Type: Article

References (97)

1. Gibeon D, Chung KF. The investigation of severe asthma to define phenotypes. Clin. Exp. Allergy 42(5), 678-692 (2012).
2. McGrath KW, Icitovic N, Boushey HA. et al.: A large subgroup of mild-To-moderate asthma is persistently noneosinophilic. Am. J. Respir. Crit. Care Med. 185(6), 612-619 (2012).
3. Haldar P, Pavord ID, Shaw DE. et al.: Cluster analysis and clinical asthma phenotypes. Am. J. Respir. Crit. Care Med. 178(3), 218-224 (2008).
4. Woodruff PG, Modrek B, Choy DF. et al.: T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med. 180(5), 388-395 (2009).
5. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am. J. Respir. Crit. Care Med. 160(5 Pt 1), 1532-1539 (1999).
6. Chung KF, Godard P, Adelroth E. et al.: Difficult/therapy-resistant asthma: The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. Eur. Respir. J. 13(5), 1198-1208 (1999).
7. Proceedings of the ATS workshop on refractory asthma: Current understanding, recommendations, and unanswered questions. American Thoracic Society. Am. J. Respir. Crit. Care Med. 162(6), 2341-2351 (2000).
8. Nair P, Gaga M, Zervas E. et al.: Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: A randomized, placebo controlled clinical triall. Clin. Exp. Allergy (2012) (In Press).
9. Wenzel SE. Asthma phenotypes: The evolution from clinical to molecular approaches. Nat. Med. 18(5), 716-725 (2012).
10. Jia G, Erickson RW, Choy DF. et al.: Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J. Allergy. Clin. Immunol. 130(3), 647-654, e10 (2012).
11. Dweik RA, Boggs PB, ErzurumSCet al. An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am. J. Respir. Crit. Care Med. 184(5), 602-615 (2011).
12. Wang R. Physiological implications of hydrogen sulfide: A whiff exploration that blossomed. Physiol. Rev. 92(2), 791-896 (2012).
13. Wang R. Shared signaling pathways among gasotransmitters. Proc. Natl Acad. Sci. USA 109(23), 8801-8802 (2012).
14. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat. Rev. Drug Discov. 6(11), 917-935 (2007).
15. Whiteman M, Le Trionnaire S, Chopra M, Fox B, Whatmore J. Emerging role of hydrogen sulfide in health and disease: Critical appraisal of biomarkers and pharmacological tools. Clin. Sci. 121(11), 459-488 (2011).
16. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J. Biochem. 146(5), 623-626 (2009).
17. Shibuya N, Tanaka M, Yoshida M. et al.: 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid. Redox Signal. 11(4), 703-714 (2009).
18. Kabil O, Banerjee R. Redox biochemistry of hydrogen sulfide. J. Biol. Chem. 285(29), 21903-21907 (2010).
19. Mikami Y, Shibuya N, Kimura Y, Nagahara N, Ogasawara Y, Kimura H. Thioredoxin and dihydrolipoic acid are required for 3-mercaptopyruvate sulfurtransferase to produce hydrogen sulfide. Biochem. J. 439(3), 479-485 (2011).
20. Olson KR, Whitfield NL. Hydrogen sulfide and oxygen sensing in the cardiovascular system. Antioxid. Redox Signal. 12(10), 1219-1234 (2010).
21. Baskar R, Li L, Moore PK. Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells. FASEB J. 21(1), 247-255 (2007).
22. Perry MM, Hui CK, Whiteman M. et al.: Hydrogen sulfide inhibits proliferation and release of IL-8 from human airway smooth muscle cells. Am. J. Respir. Cell. Mol. Biol. 45(4), 746-752 (2011).
23. Wang P, Zhang G, Wondimu T, Ross B, Wang R. Hydrogen sulfide and asthma. Exp. Physiol. 96(9), 847-852 (2011).
24. Zhu XY, Liu SJ, Liu YJ, Wang S, Ni X. Glucocorticoids suppress cystathionine gamma-lyase expression and H2S production in lipopolysaccharide- Treated macrophages. Cell Mol. Life Sci. 67(7), 1119-1132 (2010).
25. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 20(12), 2118-2120 (2006).
26. Ekundi-Valentim E, Santos KT, Camargo EA. et al.: Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat. Br. J. Pharmacol. 159(7), 1463-1474 (2010).
27. Li L, Fox B, Keeble J, Salto-Tellez M. et al.: The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells. J. Cell. Mol. Med. 17(3), 365-376 (2013).
28. Bucci M, Papapetropoulos A, Vellecco V. et al.: Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler. Thromb. Vasc. Biol. 30(10), 1998-2004 (2010).
29. Whiteman M, Li L, Kostetski I. et al.: Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem. Biophys. Res. Commun. 343(1), 303-310 (2006).
30. Whiteman M, Armstrong JS, Chu SH et al.: The novel neuromodulator hydrogen sulfide: An endogenous peroxynitrite 'scavenger'? J. Neurochem. 90(3), 765-768 (2004).
31. Fiorucci S, Orlandi S, Mencarelli A. et al.: Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br. J. Pharmacol. 150(8), 996-1002 (2007).
32. Whiteman M, Li L, Rose P, Tan CH, Parkinson DB, Moore PK. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid. Redox Signal. 12(10), 1147-1154 (2010).
33. Liu H, Bai XB, Shi S, Cao YX. Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats. J. Pharm. Pharmacol. 61(2), 207-212 (2009).
34. Tyagi N, Moshal KS, Sen U. et al.: H2S protects against methionine-induced oxidative stress in brain endothelial cells. Antioxid. Redox Signal. 11(1), 25-33 (2009).
35. Xu ZS, Wang XY, Xiao DM. et al.: Hydrogen sulfide protects MC3T3-E1 osteoblastic cells against H2O2-induced oxidative damage-implications for the treatment of osteoporosis. Free Radic. Biol. Med. 50(10), 1314-1323 (2011).
36. Mariggio MA, Minunno V, Riccardi S, Santacroce R, De Rinaldis P, Fumarulo R. Sulfide enhancement of PMN apoptosis. Immunopharmacol. Immunotoxicol. 20(3), 399-408 (1998).
37. Dufton N, Natividad J, Verdu EF, Wallace JL. Hydrogen sulfide and resolution of acute inflammation: A comparative study utilizing a novel fluorescent probe. Sci. Rep. 2, 499 (2012).
38. Chen YH, Wu R, Geng B. et al.: Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma. Cytokine 45(2), 117-123 (2009).
39. Benetti LR, Campos D, Gurgueira SA. et al.: Hydrogen sulfide inhibits oxidative stress in lungs from allergic mice in vivo. Eur. J. Pharmacol. 698(1-3), 463-469 (2013).
40. Chen YH, Wang PP, Wang XM. et al.: Involvement of endogenous hydrogen sulfide in cigarette smoke-induced changes in airway responsiveness and inflammation of rat lung. Cytokine 53(3), 334-341 (2011).
41. Han W, Dong Z, Dimitropoulou C, Su Y. Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice. Antioxid. Redox Signal. 15(8), 2121-2134 (2011).
42. Wang T, Wang L, Zaidi SR. et al.: Hydrogen sulfide attenuates particulate matter-induced human lung endothelial barrier disruption via combined reactive oxygen species scavenging and Akt activation. Am. J. Respir. Cell. Mol. Biol. 47(4), 491-496 (2012).
43. Zhang H, Zhi L, Moochhala S, Moore PK, Bhatia M. Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappaB. American journal of physiology Lung Cell. Mol. Physiol. 292(4), L960-L971 (2007).
44. Li L, Bhatia M, Zhu YZ. et al.: Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 19(9), 1196-1198 (2005).
45. Hui Y, Du J, Tang C, Bin G, Jiang H. Changes in arterial hydrogen sulfide (H(2)S) content during septic shock and endotoxin shock in rats. J. Infect. 47(2), 155-160 (2003).
46. Ang SF, Moochhala SM, Bhatia M. Hydrogen sulfide promotes transient receptor potential vanilloid 1-mediated neurogenic inflammation in polymicrobial sepsis. Crit. Care Med. 38(2), 619-628 (2010).
47. Trevisani M, Patacchini R, Nicoletti P. et al.: Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br. J. Pharmacol. 145(8), 1123-1131 (2005).
48. Bhatia M, Zhi L, Zhang H, Ng SW, Moore PK. Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 291(5), L896-L904 (2006).
49. Whiteman M, Li L, Kostetski I. et al.: Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem. Biophys. Res. Commun. 343(1), 303-310 (2006).
50. Gorg B, Foster N, Reinehr R. et al.: Benzodiazepine-induced protein tyrosine nitration in rat astrocytes. Hepatology 37(2), 334-342 (2003).
51. Wei HL, Zhang CY, Jin HF, Tang CS, Du JB. Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol. Sin. 29(6), 670-679 (2008).
52. Chung KF, Marwick JA. Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann. NY Acad. Sci. 1203, 85-91 (2010).
53. Michaeloudes C, Chang PJ, Petrou M, Chung KF. Transforming growth factor-beta and nuclear factor E2-related factor 2 regulate antioxidant responses in airway smooth muscle cells: Role in asthma. Am. J. Respir. Crit. Care Med. 184(8), 894-903 (2011).
54. Hayes JD, Ashford ML. Nrf2 orchestrates fuel partitioning for cell proliferation. Cell Metab. 16(2), 139-141 (2012).
55. Yang G, Li H, Tang G. et al.: Increased neointimal formation in cystathionine gamma-lyase deficient mice: Role of hydrogen sulfide in alpha5beta1-integrin and matrix metalloproteinase-2 expression in smooth muscle cells. J. Mol. Cell. Cardiol. 52(3), 677-688 (2012).
56. Mustafa AK, Gadalla MM, Sen N. et al.: H2S signals through protein S-sulfhydration. Sci. Signal. 2(96), ra72 (2009).
57. Yang G, Wu L, Wang R. Pro-Apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB J. 20(3), 553-555 (2006).
58. Yang G, Wu L, Bryan S, Khaper N, Mani S, Wang R. Cystathionine gamma-lyase deficiency and overproliferation of smooth muscle cells. Cardiovasc. Res. 86(3), 487-495 (2010).
59. Fang L, Li H, Tang C, Geng B, Qi Y, Liu X. Hydrogen sulfide attenuates the pathogenesis of pulmonary fibrosis induced by bleomycin in rats. Can. J. Physiol. Pharmacol. 87(7), 531-538 (2009).
60. Kubo S, Doe I, Kurokawa Y, Kawabata A. Hydrogen sulfide causes relaxation in mouse bronchial smooth muscle. J. Pharmacol. Sci. 104(4), 392-396 (2007).
61. Lim JJ, Liu YH, Khin ES, Bian JS. Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells. Am. J. Physiol. Cell. Physiol. 295(5), C1261-C1270 (2008).
62. Derwall M, Francis RC, Kida K. et al.: Administration of hydrogen sulfide via extracorporeal membrane lung ventilation in sheep with partial cardiopulmonary bypass perfusion: A proof of concept study on metabolic and vasomotor effects. Crit. Care 15(1), R51 (2011).
63. Olson KR, Whitfield NL, Bearden SE. et al.: Hypoxic pulmonary vasodilation: A paradigm shift with a hydrogen sulfide mechanism. Am. J. Physiol. RegulIntegr. Comp. Physiol. 298(1), R51-R60 (2010).
64. Prabhakar NR. Hydrogen sulfide (H(2)S): A physiologic mediator of carotid body response to hypoxia. Adv. Exp. Med. Biol. 758, 109-113 (2012).
65. Evans AM, Hardie DG, Peers C, Mahmoud A. Hypoxic pulmonary vasoconstriction: Mechanisms of oxygen-sensing. Curr. Opin. Anaesthesiol. 24(1), 13-20 (2011).
66. Modis K, Coletta C, Erdelyi K, Papapetropoulos A, Szabo C. Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J. 27(2), 601-611 (2013).
67. Fu M, Zhang W, Wu L, Yang G, Li H, Wang R. Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production. Proc. Natl Acad. Sci. USA 109(8), 2943-2948 (2012).
68. Hyspler R, Ticha A, Indrova M. et al.: A simple, optimized method for the determination of sulphide in whole blood by GC-mS as a marker of bowel fermentation processes. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 770(1-2), 255-259 (2002).
69. Richardson CJ, Magee EA, Cummings JH. A new method for the determination of sulphide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin. Chim. Acta 293(1-2), 115-125 (2000).
70. Chen YH, Yao WZ, Geng B. et al.: Endogenous hydrogen sulfide in patients with COPD. Chest 128(5), 3205-3211 (2005).
71. Chen YH, Yao WZ, Gao JZ, Geng B, Wang PP, Tang CS. Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community-Acquired lower respiratory tract infections. Respirology 14(5), 746-752 (2009).
72. Whitfield NL, Kreimier EL, Verdial FC, Skovgaard N, Olson KR. Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am. J. Physiol. RegulIntegr. Comp. Physiol. 294(6), R1930-R1937 (2008).
73. Furne J, Saeed A, Levitt MD. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am. J. Physiol. RegulIntegr. Comp. Physiol. 295(5), R1479-R1485 (2008).
74. Levitt MD, Abdel-Rehim MS, Furne J. Free and acid-labile hydrogen sulfide concentrations in mouse tissues: Anomalously high free hydrogen sulfide in aortic tissue. Antioxid. Redox Signal. 15(2), 373-378 (2011).
75. Wu R, Yao WZ, Chen YH, Geng B, Tang CS. [Plasma level of endogenous hydrogen sulfide in patients with acute asthma]. Beijing Da Xue Xue Bao 40(5), 505-508 (2008).
76. Tian M, Wang Y, Lu YQ, Yan M, Jiang YH, Zhao DY. Correlation between serum H2S and pulmonary function in children with bronchial asthma. Mol. Med. Report. 6(2), 335-358 (2012).
77. Saito J, Zhang Q, Hui C. et al.: Sputum hydrogen sulfide as a novel biomarker of obstructive neutrophilic asthma. J. Allergy Clin. Immunol. 131(1), 232-234 (2013).
78. Li L, Whiteman M, Moore PK. Dexamethasone inhibits lipopolysaccharide- induced hydrogen sulphide biosynthesis in intact cells and in an animal model of endotoxic shock. J. Cell. Mol. Med. 13(8b), 2684-2692 (2009).
79. Hilty M, Burke C, Pedro H. et al.: Disordered microbial communities in asthmatic airways. PLoS ONE 5(1), e8578 (2010).
80. Huang YJ, Nelson CE, Brodie EL. et al.: Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J. Allergy Clin. Immunol. 127(2), 372-381 (2011).
81. Shatalin K, Shatalina E, Mironov A, Nudler E. H2S: A universal defense against antibiotics in bacteria. Science 334(6058), 986-990 (2011).
82. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: Inflammation, immunity, and tissue repair and destruction. Eur. Respir. J. 31(6), 1334-1356 (2008).
83. Chen YH, Yao WZ, Ding YL, Geng B, Lu M, Tang CS. Effect of theophylline on endogenous hydrogen sulfide production in patients with COPD. Pulm. Pharmacol. Ther. 21(1), 40-46 (2008).
84. Morselli-Labate AM, Fantini L, Pezzilli R. Hydrogen sulfide, nitric oxide and a molecular mass 66 u substance in the exhaled breath of chronic pancreatitis patients. Pancreatology 7(5-6), 497-504 (2007).
85. Studer SM, Orens JB, Rosas I. et al.: Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection. J. Heart Lung Transplantation 20(11), 1158-1166 (2001).
86. Toombs CF, Insko MA, Wintner EA. et al.: Detection of exhaled hydrogen sulphide gas in healthy human volunteers during intravenous administration of sodium sulphide. Br. J. Clin. Pharmacol. 69(6), 626-636 (2010).
87. Kamboures MA, Blake DR, Cooper DM. et al.: Breath sulfides and pulmonary function in cystic fibrosis. Proc. Natl Acad. Sci. USA 102(44), 15762-15767 (2005).
88. Nakano Y, Yoshimura M, Koga T. Correlation between oral malodor and periodontal bacteria. Microbes Infect. 4(6), 679-683 (2002).
89. Morita M, Wang HL. Relationship between sulcular sulfide level and oral malodor in subjects with periodontal disease. J Periodontol. 72(1), 79-84.
90. Lee H, Kho HS, Chung JW, Chung SC, Kim YK. Volatile sulfur compounds produced by Helicobacter pylori. J. Clin. Gastroenterol. 40(5), 421-426 (2006).
91. Picton R, Eggo MC, Merrill GA, Langman MJ, Singh S. Mucosal protection against sulphide: Importance of the enzyme rhodanese. Gut 50(2), 201-205 (2002).
92. Rowan FE, Docherty NG, Coffey JC, O'Connell PR. Sulphate-reducing bacteria and hydrogen sulphide in the aetiology of ulcerative colitis. Br. J. Surg. 96(2), 151-158 (2009).
93. Gaston B, Singel D, Doctor A, Stamler JS. S-nitrosothiol signaling in respiratory biology. Am. J. Respir. Crit. Care Med. 173(11), 1186-1193 (2006).
94. Que LG, Liu L, Yan Y. et al.: Protection from experimental asthma by an endogenous bronchodilator. Science 308(5728), 1618-1621 (2005).
95. Corradi M, Montuschi P, Donnelly LE, Pesci A, Kharitonov SA, Barnes PJ. Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am. J. Respir. Crit. Care Med. 163(4), 854-858 (2001).
96. Kubo S, Kurokawa Y, Doe I, Masuko T, Sekiguchi F, Kawabata A. Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase. Toxicology 241(1-2), 92-97 (2007).
97. Yanfei W, Lin S, Junbao D, Chaoshu T. Impact of L-Arginine on hydrogen sulfide/ cystathionine-gamma-lyase pathway in rats with high blood flow-induced pulmonary hypertension. Biochem. Biophys. Res. Commun. 345(2), 851-857 (2006).